Your browser doesn't support javascript.
loading
EphA4 promotes cell proliferation and cell adhesion-mediated drug resistance via the AKT pathway in multiple myeloma.
Ding, Linlin; Shen, Yaodong; Ni, Jing; Ou, Yiqing; Ou, Yangyu; Liu, Hong.
Afiliación
  • Ding L; 1 Department of Hematology, Affiliated Hospital of Nantong University, Nantong University, Nantong, People's Republic of China.
  • Shen Y; 1 Department of Hematology, Affiliated Hospital of Nantong University, Nantong University, Nantong, People's Republic of China.
  • Ni J; 1 Department of Hematology, Affiliated Hospital of Nantong University, Nantong University, Nantong, People's Republic of China.
  • Ou Y; 1 Department of Hematology, Affiliated Hospital of Nantong University, Nantong University, Nantong, People's Republic of China.
  • Ou Y; 2 Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, People's Republic of China.
  • Liu H; 1 Department of Hematology, Affiliated Hospital of Nantong University, Nantong University, Nantong, People's Republic of China.
Tumour Biol ; 39(3): 1010428317694298, 2017 Mar.
Article en En | MEDLINE | ID: mdl-28351297
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptor EphA4 / Quinasa 5 Dependiente de la Ciclina / Proteína Oncogénica v-akt / Mieloma Múltiple Límite: Humans Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptor EphA4 / Quinasa 5 Dependiente de la Ciclina / Proteína Oncogénica v-akt / Mieloma Múltiple Límite: Humans Idioma: En Revista: Tumour Biol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article